Author:
Hsin Chih-hsuan,Stoffel Marc S.,Gazzaz Malaz,Schaeffeler Elke,Schwab Matthias,Fuhr Uwe,Taubert Max
Abstract
AbstractEffects of different genotypes on the pharmacokinetics of probe substrates may support their use as phenotyping agents for the activity of the respective enzyme or transporter. Digoxin is recommended as a probe substrate to assess the activity of the transporter P-glycoprotein (P-gp) in humans. Current studies on the individual effects of three commonly investigated single nucleotide polymorphisms (SNPs) of the ABCB1 gene encoding P-gp (C1236T, G2677T/A, and C3435T) on digoxin pharmacokinetics are inconclusive. Since SNPs are in incomplete linkage disequilibrium, considering combinations of these SNPs might be necessary to assess the role of polymorphisms in digoxin pharmacokinetics accurately. In this study, the relationship between SNP combinations and digoxin pharmacokinetics was explored via a population pharmacokinetic approach in 40 volunteers who received oral doses of 0.5 mg digoxin. Concerning the SNPs 1236/2677/3435, the following combinations were evaluated: CGC, CGT, and TTT. Carriers of CGC/CGT and TTT/TTT had 35% higher apparent bioavailability compared to the reference group CGC/CGC, while no difference was seen in CGC/TTT carriers. No significant effect on renal clearance was observed. The population pharmacokinetic model supports the use of oral digoxin as a phenotyping substrate of intestinal P-gp, but not to assess renal P-gp activity.
Funder
Bayer HealthCare AG
Government of Saudi Arabia
European Commission Horizon 2020 UPGx
Robert Bosch Stiftung
Publisher
Springer Science and Business Media LLC
Reference73 articles.
1. Benet, L. Z., Bowman, C. M. & Sodhi, J. K. How transporters have changed basic pharmacokinetic understanding. AAPS J. 21, 103 (2019).
2. Yee, S. W. et al. Influence of transporter polymorphisms on drug disposition and response: A perspective from the International Transporter Consortium. Clin. Pharmacol. Ther. 104, 803–817 (2018).
3. Franke, R., Gardner, E. & Sparreboom, A. Pharmacogenetics of drug transporters. Curr. Pharm. Des. 16, 220–230 (2010).
4. Juliano, R. L. & Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta Biomembr. 455, 152–162 (1976).
5. Cascorbi, I. P-glycoprotein: Tissue distribution, substrates, and functional consequences of genetic variations. In Handbook of Experimental Pharmacology Vol. 201 (eds Fromm, M. & Kim, R.) 261–283 (Springer, Berlin, 2011).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献